These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7119300)

  • 21. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
    Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
    Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.
    Lee DA; Taylor GM; Walker JG; James VH
    Br J Clin Pharmacol; 1979 May; 7(5):523-8. PubMed ID: 475947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.
    Rose JQ; Yurchak AM; Meikle AW; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):1-14. PubMed ID: 7229914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
    Frey FJ; Horber FF; Frey BM
    Clin Pharmacol Ther; 1988 Nov; 44(5):510-21. PubMed ID: 2972434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone.
    Frey FJ; Lozada F; Guentert T; Frey BM
    Eur J Clin Pharmacol; 1981 Feb; 19(3):209-12. PubMed ID: 7215419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma prednisolone levels in man following administration in plain and enteric-coated forms.
    Wilson CG; May CS; Paterson JW
    Br J Clin Pharmacol; 1977 Jun; 4(3):351-5. PubMed ID: 901703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of pharmacokinetic interaction between St. John's wort and prednisone.
    Bell EC; Ravis WR; Chan HM; Lin YJ
    Ann Pharmacother; 2007 Nov; 41(11):1819-24. PubMed ID: 17925494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration].
    Brion N; Pibarot ML; Atienza P; Robin P; Carbon C
    Presse Med; 1988 Apr; 17(12):569-71. PubMed ID: 2967477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone.
    Hsueh WA; Paz-Guevara A; Bledsoe T
    J Clin Endocrinol Metab; 1979 May; 48(5):748-52. PubMed ID: 429520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.
    Morrison PJ; Bradbrook ID; Rogers HJ
    Br J Clin Pharmacol; 1977 Oct; 4(5):597-603. PubMed ID: 911606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
    Rose JQ; Yurchak AM; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of two tablet preparations of carbimazole in man.
    Shenfield GM; Ilett KF; Tjokrosetio R; Tearne P
    Clin Exp Pharmacol Physiol; 1979; 6(5):479-85. PubMed ID: 583031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
    Colburn WA; Sibley CR; Buller RH
    J Pharm Sci; 1976 Jul; 65(7):997-1001. PubMed ID: 957135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spironolactone. II. Bioavailability.
    Karim A; Zagarella J; Hutsell TC; Chao A; Baltes BJ
    Clin Pharmacol Ther; 1976 Feb; 19(2):170-6. PubMed ID: 1261154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Removal of prednisone and prednisolone during plasma exchange].
    Assogba U; Baumelou A; Pecquinot MA; Raymond F; Durande JP; Lenoir G; Rottembourg J
    Ann Med Interne (Paris); 1988; 139 Suppl 1():38-9. PubMed ID: 3247989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence of different prednisolone tablet formulations.
    Luippold G; Benöhr P; Schneider S; Marto M; Mühlbauer B
    Arzneimittelforschung; 2001; 51(8):638-42. PubMed ID: 11556124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.